Latest News Releases From The Newsroom
Earnings In Focus: Gilead Sciences, Uber, and Lucid Group Gear Up
November 04th, 2023
On Tuesday, November 7, several significant companies are slated to unveil their financial results, including: Gilead Sciences, Inc. (Nasdaq: GILD), a leading biopharmaceutical company, will release its third-quarter 2023 financial results and gui. Read more
Ryanair, Vertex Pharmaceuticals, and Celanese's Earnings Preview
November 04th, 2023
On Monday, November 6, several notable companies are set to disclose their financial reports, including: Ryanair Holdings plc (Nasdaq: RYAAY), a leading international airline, is poised to reveal its second-quarter and first-half fiscal 2024 finan. Read more
Roku's Q3 Revenue Beats Expectations; Nutrien Misses Estimates
November 01st, 2023
Roku, Inc. (Nasdaq: ROKU) reported a third-quarter 2023 loss of $(2.33) per share, falling short of the consensus estimate loss of $(2.08) per share. Despite the loss, the company's quarterly revenues reached $912.02 million, surpassing analysts' exp. Read more
October Vehicle Delivery: Li Auto, XPeng, and NIO By The Numbers
November 01st, 2023
In the electric vehicle industry, major players such as Li Auto Inc. (Nasdaq: LI), XPeng Inc. (NYSE: XPEV), and NIO Inc. (NYSE: NIO) have reported their vehicle delivery figures for October 2023. Li Auto achieved a milestone by delivering 40,422 v. Read more
Tonix Pharma's TNX-601 ER Trial Misses Endpoint; AMD Posts Upbeat Results
November 01st, 2023
Shares of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) experienced a drastic over 20% decline in after-hours trading following the release of Phase 2 proof-of-concept study results for TNX-601 ER, intended for patients with major depressive dis. Read more
Amgen Posts Mixed Results; Repligen Beats Estimates
October 31st, 2023
Amgen Inc. (Nasdaq: AMGN), a global biotechnology company, posted third-quarter 2023 earnings per share (EPS) of $4.96, surpassing the consensus EPS estimate of $4.66. The company's quarterly revenues stood at $6.90 billion, slightly below analysts' . Read more
Pulmonx Beats Estimates; Strategic Move Boosts TransCode Therapeutics
October 30th, 2023
Pulmonx Corporation (Nasdaq: LUNG) reported a narrower loss than expected in the third quarter of 2023, posting a loss of $(0.39) per share, surpassing the consensus estimate loss of $(0.43) per share. The company's quarterly sales stood at $17.67 mi. Read more
President Biden Takes Action: New Standards for AI Safety and Security
October 30th, 2023
President Joe Biden has taken a significant step in ensuring the responsible development and management of artificial intelligence (AI) with the issuance of a landmark Executive Order. The order marks a pivotal moment in America's commitment to harne. Read more
Earnings Countdown: Apple, Ferrari, and Novo Nordisk Take the Stage
October 29th, 2023
On Thursday, November 2, a range of significant companies are anticipated to unveil their financial performance, including: Apple Inc. (Nasdaq: AAPL), a renowned tech giant, is set to disclose its fourth-quarter fiscal 2023 financial results after. Read more
Ahead of Earnings: QUALCOMM, CVS Health, and McKesson in the Spotlight
October 29th, 2023
On Wednesday, November 1, several key companies are poised to unveil their financial performance, including: QUALCOMM Incorporated (Nasdaq: QCOM), a leading semiconductor and telecommunications company, will announce its financial results for the . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024Key Metrics: CyberArk Software, Hudbay Minerals, and Sonos Earnings Due
November 11th, 2024Earnings: What to Expect from Occidental Petroleum, Rocket Lab, and CAE
November 10th, 2024Earnings Countdown: Home Depot, Sea Limited, and Natera in the Spotlight
November 10th, 2024Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024
Member Login